02 9541 3500UNSW RNA Institute making next generation RNA therapeutics and vaccines using Micropore Pathfinder
The UNSW RNA Institute is a major part of Australia’s RNA ecosystem, uniting researchers from biology, chemistry, medicine and connecting them with the facilities they need to translate their research into RNA treatments, from cancer therapies to personalised medicines and vaccines. For all the tantalising potential of RNA science, the progress has been stymied by a roadblock of scale – but not anymore!
The Pathfinder PRO 250 from Micropore Technologies meets the need for a faster and cheaper high-throughput manufacturing method. Pathfinder offers a GMP compliant approach from the earliest possible stage through to manufacturing, that is also tuneable in size to access various tissues or specific drug targets.
With the addition of their new Micropore Pathfinder PRO 250 the UNSW RNA Institute can create formulations for the entire spectrum of mRNA–LNP production, ranging from initial discovery volumes to GMP-production scale. The UNSW RNA Institute is looking forward to advancing critical research and contributing to the development of new RNA based therapies.
CONTACT US FOR A DEMO TODAY!
More publications/citations:
Muattaz Hussain, Burcu Binici, Liam O’Connor, Yvonne Perrie, Production of mRNA lipid nanoparticles using advanced crossflow micromixing, Journal of Pharmacy and Pharmacology, Volume 76, Issue 12, December 2024, Pages 1572–1583, https://doi.org/10.1093/jpp/rgae122
Democratising medicine together
creating-a-genetic-medicine-manufacturing-ecosystem
creating-a-genetic-medicine-manufacturing-ecosystem-part-2
creating-a-genetic-medicine-manufacturing-ecosystem-part-3